Oncology Commitment 2022: Bertrand Renaud’s interview
For several years, Servier has been committed to developing treatments for cancers for which therapeutic needs are, for the most part, not yet covered and which are hard to treat, such as digestive, hematologic, and childhood cancers.
Discover Servier’s patient engagement with Bertrand Renaud, Chief Patient Officer.
